{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T13:35:14Z","timestamp":1709472914349},"posted":{"date-parts":[[2023,6,13]]},"group-title":"In Review","reference-count":53,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,6,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p><jats:bold>Background: <\/jats:bold>Duchenne muscular dystrophy (DMD) is a severe form of muscular dystrophy without an effective treatment, caused by mutations in the <jats:italic>DMD<\/jats:italic> gene, leading to the absence of dystrophin. DMD results in muscle weakness, loss of ambulation and death at an early age. Metabolomics studies in <jats:italic>mdx<\/jats:italic> mice, the most used model for DMD, reveal changes in metabolites associated with muscle degeneration and aging. In DMD, the tongue muscles exhibit unique behavior, initially showing partial protection against inflammation but later experiencing fibrosis and loss of muscle fibers. Certain metabolites and proteins, like TNF-\u03b1 and TGF-\u03b2, are potential biomarkers for dystrophic muscle characterization.\n<jats:bold>Methods: <\/jats:bold>To investigate disease progression and aging, we utilized young (1-month old) and old (21-25 months old) <jats:italic>mdx<\/jats:italic> and wild-type mice. Metabolite changes were analyzed using 1-H Nuclear Magnetic Resonance, while TNF-\u03b1 and TGF-\u03b2 were assessed using Western blotting to examine inflammation, and fibrosis. Morphometric analysis was conducted to assess the extent of myofiber damage between groups.\n<jats:bold>Results: <\/jats:bold>The histological analysis of the tongue showed no differences between groups. No differences were found between the concentrations of metabolites from wild type or <jats:italic>mdx<\/jats:italic> animals of the same age. The metabolites alanine, methionine, 3-methylhistidine were higher, and taurine and glycerol were lower in young animals in both wild type and <jats:italic>mdx<\/jats:italic> (p &lt; 0.001). The metabolites glycine (p &lt; 0.001) and glutamic acid (p = 0.0018) were different only in the <jats:italic>mdx<\/jats:italic> groups, being higher in young <jats:italic>mdx<\/jats:italic> mice. Acetic acid, phosphocreatine, isoleucine, succinic acid, creatine and the proteins TNF-\u03b1 and TGF-\u03b2 had no difference in the analysis between groups (p &gt; 0.05).\n<jats:bold>Conclusions: <\/jats:bold>Surprisingly, histological and protein analysis reveals that the tongue of young and old <jats:italic>mdx<\/jats:italic> animals is protected from severe myonecrosis observed in other muscles. The metabolites alanine, methionine, 3-methylhistidine, taurine, and glycerol may be effective for specific assessments, although their use for disease progression monitoring should be cautious due to age-related changes. Acetic acid, phosphocreatine, isoleucine, succinate, creatine, TNF-\u03b1, and TGF-\u03b2 do not vary with aging and remain constant in spared muscles, suggesting their potential as specific biomarkers for DMD progression independent of aging.<\/jats:p>","DOI":"10.21203\/rs.3.rs-3038923\/v1","type":"posted-content","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T14:38:06Z","timestamp":1686667086000},"source":"Crossref","is-referenced-by-count":0,"title":["Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle"],"prefix":"10.21203","author":[{"given":"Marcelo dos Santos Voltani","family":"Lorena","sequence":"first","affiliation":[{"name":"Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, S\u00e3o Paulo State University (UNESP)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela Kato","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, S\u00e3o Paulo State University (UNESP)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Ferretti","sequence":"additional","affiliation":[{"name":"Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, S\u00e3o Paulo State University (UNESP)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.A. Nagana","family":"Gowda","sequence":"additional","affiliation":[{"name":"Northwest Metabolomics Research Center; Mitochondria and Metabolism Center, Anesthesiology and Pain Medicine, University of Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy L.","family":"Odom","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wellstone Muscular Dystrophy Specialized Research Center, University of Washington School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Chamberlain","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wellstone Muscular Dystrophy Specialized Research Center, University of Washington School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cintia Yuri","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, S\u00e3o Paulo State University (UNESP)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for duchenne muscular dystrophy","volume":"71","author":"Mendell JR","year":"2012","unstructured":"Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier-Foster J, et al. Evidence-based path to newborn screening for duchenne muscular dystrophy. Annals of Neurology. 2012 Mar;71(3):304\u201313. DOI: 10.1002\/ana.23528","journal-title":"Annals of Neurology."},{"issue":"6","key":"ref2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"The protein product of the duchenne muscular dystrophy locus","volume":"51","author":"Hoffman EP","unstructured":"Hoffman EP, Brown RH, Kunkel LM. Dystrophin: The protein product of the duchenne muscular dystrophy locus. Cell. 1987 Dec; 51(6):919\u201328. DOI: https:\/\/doi.org\/10.1016\/0092-8674(87)90579-4","journal-title":"Cell. 1987 Dec"},{"issue":"6","key":"ref3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/humu.20976","article-title":"Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase","volume":"30","author":"Tuffery-Giraud S","year":"2009","unstructured":"Tuffery-Giraud S, B\u00e9roud C, Leturcq F, Yaou RB, Hamroun D, Michel-Calemard L, et al. Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Human Mutation. 2009 Jun;30(6):934\u201345. DOI: 10.1002\/humu.20976","journal-title":"Human Mutation."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.18.8307","author":"Tinsley JM","year":"1994","unstructured":"Tinsley JM, Blake DJ, Zuellig RA, Davies KE. Increasing complexity of the dystrophin-associated protein complex. Proceedings of the National Academy of Sciences. 1994 Aug 30];91(18):8307\u201313. DOI: 10.1073\/pnas.91.18.8307"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-003-0484-1","author":"Bogdanovich S","year":"2004","unstructured":"Bogdanovich S, Perkins KJ, Krag TOB, Khurana TS. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. Journal of Molecular Medicine. 2004 Feb 1;82(2):102\u201315. DOI: 10.1007\/s00109-003-0484-1"},{"issue":"7","key":"ref6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00109-003-0484-1","article-title":"Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis","volume":"27","author":"Landfeldt E","unstructured":"Landfeldt E, Thompson R, Sejersen T, McMillan HJ, Kirschner J, Lochm\u00fcller H. Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. European Journal of Epidemiology. 2020 Feb 27;35(7):643\u201353. DOI: 10.1007\/s00109-003-0484-1","journal-title":"European Journal of Epidemiology. 2020 Feb"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.4.1189","author":"Bulfield G","year":"1984","unstructured":"Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proceedings of the National Academy of Sciences. 1984 Feb];81(4):1189\u201392. DOI: 10.1073\/pnas.81.4.1189"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.018424","author":"McGreevy JW","year":"2015","unstructured":"McGreevy JW, Hakim CH, McIntosh MA, Duan D. Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Disease Models & Mechanisms. 2015 Mar 1;8(3):195\u2013213. DOI:10.1242\/dmm.018424"},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2990.1988.tb00866.x","article-title":"The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation","volume":"14","author":"Coulton GR","year":"1988","unstructured":"Coulton GR, Morgan JE, Partridge TA, Sloper JC. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathology and Applied Neurobiology. 1988 Feb;14(1):53\u201370. DOI: 10.1111\/j.1365-2990.1988.tb00866.x","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"ref10","doi-asserted-by":"publisher","author":"Chamberlain JS","unstructured":"Chamberlain JS, Metzger J, Reyes M, Townsend D, Faulkner JA. Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. The FASEB Journal. 2007 Mar 14;21(9):2195\u2013204. DOI: 10.1096\/fj.06-7353com","DOI":"10.1096\/fj.06-7353com"},{"issue":"4","key":"ref11","article-title":"Systems biology approaches to disease marker discovery","volume":"28","author":"Donald S","year":"2013","unstructured":"Donald S, Chen R, Snyder M. Systems biology approaches to disease marker discovery. Disease markers. 2013;28(4). DOI: 0.3233\/DMA-2010-0707","journal-title":"Disease markers"},{"issue":"3","key":"ref12","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1021\/pr800070p","article-title":"A Combined Metabolomic and Proteomic Investigation of the Effects of a Failure to Express Dystrophin in the Mouse Heart","volume":"7","author":"Gulston MK","unstructured":"Gulston MK, Rubtsov DV, Atherton HJ, Clarke K, Davies KE, Lilley KS, et al. A Combined Metabolomic and Proteomic Investigation of the Effects of a Failure to Express Dystrophin in the Mouse Heart. Journal of Proteome Research [Internet]. 2008 Apr 3;7(5):2069\u201377. DOI: 10.1021\/pr800070p","journal-title":"Journal of Proteome Research [Internet]. 2008 Apr"},{"issue":"8","key":"ref13","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.mri.2012.04.003","article-title":"Metabolic profile of dystrophic mdx mouse muscles analyzed with in vitro magnetic resonance spectroscopy (MRS)","volume":"30","author":"Martins-Bach AB","year":"2012","unstructured":"Martins-Bach AB, Bloise AC, Vainzof M, Rahnamaye Rabbani S. Metabolic profile of dystrophic mdx mouse muscles analyzed with in vitro magnetic resonance spectroscopy (MRS). Magnetic Resonance Imaging. 2012 Oct;30(8):1167\u201376. DOI: 10.1016\/j.mri.2012.04.003","journal-title":"Magnetic Resonance Imaging."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clnesp.2017.03.005","article-title":"Effects of dietary omega-3 on dystrophic cardiac and diaphragm muscles as evaluated by 1H magnetic resonance spectroscopy: Metabolic profile and calcium-related proteins","volume":"20","author":"Maur\u00edcio AF","year":"2017","unstructured":"Maur\u00edcio AF, de Carvalho SC, Santo Neto H, Marques MJ. Effects of dietary omega-3 on dystrophic cardiac and diaphragm muscles as evaluated by 1H magnetic resonance spectroscopy: Metabolic profile and calcium-related proteins. Clinical Nutrition ESPEN. 2017 Aug;20:60\u20137. DOI: 10.1016\/j.clnesp.2017.03.005","journal-title":"Clinical Nutrition ESPEN"},{"issue":"2","key":"ref15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1460-6984.2012.00197.x","article-title":"Dysphagia in Duchenne muscular dystrophy assessed by validated questionnaire","volume":"48","author":"Archer SK","year":"2013","unstructured":"Archer SK, Garrod R, Hart N, Miller S. Dysphagia in Duchenne muscular dystrophy assessed by validated questionnaire. International Journal of Language & Communication Disorders. 2013 Mar;48(2):240\u20136. DOI: 10.1111\/j.1460-6984.2012.00197.x","journal-title":"International Journal of Language & Communication Disorders"},{"issue":"6","key":"ref16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nmd.2016.03.008","article-title":"Dystrophic changes in masticatory muscles related chewing problems and malocclusions in Duchenne muscular dystrophy","volume":"26","author":"Engel-Hoek L","year":"2016","unstructured":"van den Engel-Hoek L, de Groot IJM, Sie LT, van Bruggen HW, de Groot SAF, Erasmus CE, et al. Dystrophic changes in masticatory muscles related chewing problems and malocclusions in Duchenne muscular dystrophy. Neuromuscular Disorders. 2016 Jun;26(6):354\u201360. DOI: 10.1016\/j.nmd.2016.03.008","journal-title":"Neuromuscular Disorders."},{"issue":"4","key":"ref17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.archoralbio.2010.02.005","article-title":"Histological changes in masticatory muscles of mdx mice","volume":"55","author":"Spassov A","unstructured":"Spassov A, Gredes T, Gedrange T, Lucke S, Pavlovic D, Kunert-Keil C. Histological changes in masticatory muscles of mdx mice. Archives of Oral Biology. 2010 Apr];55(4):318\u201324. DOI: 10.1016\/j.archoralbio.2010.02.005","journal-title":"Archives of Oral Biology. 2010 Apr]"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DNND.S121099","article-title":"Biomarkers of Duchenne muscular dystrophy: current findings","volume":"8","author":"Al-Khalili Szigyarto C","unstructured":"Al-Khalili Szigyarto C, Spitali P. Biomarkers of Duchenne muscular dystrophy: current findings. Degenerative Neurological and Neuromuscular Disease. 2018 Jan;Volume 8:1\u201313. DOI: 10.2147\/DNND.S121099","journal-title":"Degenerative Neurological and Neuromuscular Disease. 2018 Jan;Volume"},{"issue":"2","key":"ref19","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.043638","article-title":"Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress","volume":"13","author":"Grounds MD","year":"2020","unstructured":"Grounds MD, Terrill JR, Al-Mshhdani BA, Duong MN, Radley-Crabb HG, Arthur PG. Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress. Disease Models & Mechanisms. 2020 Mar;Volume\u00a013(2). DOI:10.1242\/dmm.043638","journal-title":"Disease Models & Mechanisms"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21154","author":"Ferretti R","year":"2009","unstructured":"Ferretti, R., Marques, M. J., Pertille, A., & Santo Neto, H. (2009). Sarcoplasmic-endoplasmic-reticulum Ca2+-ATPase and calsequestrin are overexpressed in spared intrinsic laryngeal muscles of dystrophin-deficient mdx mice. Muscle & Nerve. 2019 May;39(5), 609\u2013615. DOI: https:\/\/doi.org\/10.1002\/mus.21154"},{"key":"ref21","doi-asserted-by":"publisher","author":"Sukumaran DK","unstructured":"Sukumaran DK, Garcia E, Hua J, Tabaczynski W, Odunsi K, Andrews C, et al. Standard operating procedure for metabonomics studies of blood serum and plasma samples using a 1H-NMR micro-flow probe. Magnetic Resonance in Chemistry. 2009 Aug 18;47(S1):S81\u20135. DOI: 10.1002\/mrc.2469","DOI":"10.1002\/mrc.2469"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Wishart, D. S., Guo, A., Oler, E., Wang, F., Anjum, A., Peters, H., Dizon, R., Sayeeda, Z., Tian, S., Lee, B. L., Berjanskii, M., Mah, R., Yamamoto, M., Jovel, J., Torres-Calzada, C., Hiebert-Giesbrecht, M., Lui, V. W., Varshavi, D., Varshavi, D., Allen, D., \u2026 Gautam, V. (2022). HMDB 5.0: the Human Metabolome Database for 2022. Nucleic acids research, 50(D1), D622\u2013D631. https:\/\/doi.org\/10.1093\/nar\/gkab1062","DOI":"10.1093\/nar\/gkab1062"},{"key":"ref23","author":"Weljie AM","year":"2006","unstructured":"Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM. Targeted Profiling: Quantitative Analysis of 1H NMR Metabolomics Data. Analytical Chemistry [Internet]. 2006 May 17;78(13):4430\u201342. DOI: 10.1021\/ac060209g"},{"issue":"11","key":"ref24","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","article-title":"Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts","volume":"2","author":"Beckonert O","unstructured":"Beckonert O, Keun HC, Ebbels TMD, Bundy J, Holmes E, Lindon JC, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nature Protocol. 2007 Oct 25.];2(11):2692\u2013703. DOI: 10.1038\/nprot.2007.376","journal-title":"Nature Protocol. 2007 Oct"},{"issue":"2","key":"ref25","article-title":"Differential expression of genes involved in the calcium homeostasis in masticatory muscles of MDX mice","volume":"65","author":"Kunert-Keil CH","year":"2014","unstructured":"Kunert-Keil CH; Gredes T; Lucke S; Botzenhart U; Dominiak M; Gedrange T. Differential expression of genes involved in the calcium homeostasis in masticatory muscles of MDX mice. Journal of physiology and pharmacology: an official journal of the Polish Physiological Society. 2014;65(2).","journal-title":"Journal of physiology and pharmacology: an official journal of the Polish Physiological Society"},{"key":"ref26","volume-title":"Robbins e Cotran Pathologic Basis of Disease","author":"Kumar V","year":"2010","unstructured":"Kumar, V.; Abbas, A.; Fausto, N. Robbins e Cotran Pathologic Basis of Disease. 8th. ed. Rio de Janeiro: Elsevier, 2010;","edition":"8"},{"issue":"5","key":"ref27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/iep.12142","article-title":"Changes in calsequestrin, TNF-\u03b1, TGF-\u03b2 and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles","volume":"96","author":"Maranh\u00e3o J","year":"2015","unstructured":"Maranh\u00e3o J, de Oliveira Moreira D, Maur\u00edcio AF, de Carvalho SC, Ferretti R, Pereira JA, et al. Changes in calsequestrin, TNF-\u03b1, TGF-\u03b2 and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles. International Journal of Experimental Pathology. 2015 Oct;96(5):285\u201393. DOI: 10.1111\/iep.12142","journal-title":"International Journal of Experimental Pathology"},{"issue":"3","key":"ref28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mus.20697","article-title":"Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy","volume":"35","author":"Marques MJ","year":"2007","unstructured":"Marques MJ, Ferretti R, Vomero VU, Minatel E, Neto HS. Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy. Muscle & Nerve. 2007;35(3):349\u201353. DOI: 10.1002\/mus.20697","journal-title":"Muscle & Nerve"},{"issue":"1","key":"ref29","first-page":"16","article-title":"Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age","volume":"30","author":"Messina S","year":"2011","unstructured":"Messina S, Vita GL, Aguennouz M, Sframeli M, Romeo S, Rodolico C, et al. Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age. Acta myologica: myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology. 2011;30(1):16\u201323.","journal-title":"Acta myologica: myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.exger.2017.03.005","article-title":"Age-related changes in skeletal muscle composition: A pilot nuclear magnetic resonance spectroscopy study in mice","volume":"92","author":"Sobolev AP","year":"2017","unstructured":"Sobolev, A. P., Mannina, L., Costanzo, M., Cisterna, B., Malatesta, M., & Zancanaro, C. (2017). Age-related changes in skeletal muscle composition: A pilot nuclear magnetic resonance spectroscopy study in mice. Experimental Gerontology. 2017 Jun;92, 23\u201327. DOI: https:\/\/doi.org\/10.1016\/j.exger.2017.03.005","journal-title":"Experimental Gerontology. 2017"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.biocel.2015.07.016","article-title":"Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy","volume":"66","author":"Terrill JR","unstructured":"Terrill JR, Grounds MD, Arthur PG. Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy. The International Journal of Biochemistry & Cell Biology 2015 Sep;66:141\u20138. DOI: 10.1016\/j.biocel.2015.07.016","journal-title":"The International Journal of Biochemistry & Cell Biology 2015 Sep"},{"issue":"1","key":"ref32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1006\/abio.2001.5096","article-title":"Metabolic Profiling of Genetic Disorders: A Multitissue 1H Nuclear Magnetic Resonance Spectroscopic and Pattern Recognition Study into Dystrophic Tissue","volume":"293","author":"Griffin JL","year":"2001","unstructured":"Griffin JL, Williams HJ, Sang E, Clarke K, Rae C, Nicholson JK. Metabolic Profiling of Genetic Disorders: A Multitissue 1H Nuclear Magnetic Resonance Spectroscopic and Pattern Recognition Study into Dystrophic Tissue. Analytical Biochemistry. 2001 Jun;293(1):16\u201321. DOI: 10.1006\/abio.2001.5096","journal-title":"Analytical Biochemistry"},{"issue":"2","key":"ref33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-0185(199810)252:2<311::AID-AR17>3.0.CO;2-Q","article-title":"Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-Deficient muscles","volume":"252","author":"McIntosh LM","year":"1998","unstructured":"McIntosh LM, Garrett KL, Megeney L, Rudnicki MA, Anderson JE. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-Deficient muscles. The Anatomical Record. 1998 Oct];252(2):311\u201324. DOI: 10.1002\/(SICI)1097-0185(199810)252:2<311::AID-AR17>3.0.CO;2-Q","journal-title":"The Anatomical Record"},{"issue":"4","key":"ref34","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/s0387-7604(12)80071-4","article-title":"Glucose, free fatty acid and ketone body metabolism in duchenne muscular dystrophy","volume":"12","author":"Nishio H","unstructured":"Nishio H, Wada H, Matsuo T, Horikawa H, Takahashi K, Nakajima T, et al. Glucose, free fatty acid and ketone body metabolism in duchenne muscular dystrophy. Brain and Development. 1990 Jan;12(4):390\u2013402. DOI: 10.1016\/s0387-7604(12)80071-4","journal-title":"Brain and Development. 1990"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cca.2017.12.036","article-title":"Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis","volume":"478","author":"Srivastava NK","year":"2018","unstructured":"Srivastava NK, Yadav R, Mukherjee S, Sinha N. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis. Clinica Chimica Acta. 2018 Mar;478:171\u201381. DOI: 10.1016\/j.cca.2017.12.036","journal-title":"Clinica Chimica Acta"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089277","author":"Radley-Crabb HG","year":"2014","unstructured":"Radley-Crabb HG, Marini JC, Sosa HA, Castillo LI, Grounds MD, Fiorotto ML. Dystropathology Increases Energy Expenditure and Protein Turnover in the Mdx Mouse Model of Duchenne Muscular Dystrophy. Fraidenraich D, editor. PLoS ONE. 2014 Feb 19;9(2):e89277. DOI:10.1371\/journal.pone.0089277"},{"issue":"1","key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31753-3","article-title":"Integrative effects of dystrophin loss on metabolic function of the mdx mouse","volume":"11","author":"Strakova J","unstructured":"Strakova J, Kamdar F, Kulhanek D, Razzoli M, Garry DJ, Ervasti JM, et al. Integrative effects of dystrophin loss on metabolic function of the mdx mouse. Scientific Reports. 2018 Sep 11.;8(1). DOI: 10.1038\/s41598-018-31753-3","journal-title":"Scientific Reports. 2018 Sep"},{"issue":"1","key":"ref38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.nmd.2004.09.011","article-title":"The ontogeny of soleus muscles in mdx and wild type mice","volume":"15","author":"Sch\u00e4fer R","year":"2005","unstructured":"Sch\u00e4fer R, Zweyer M, Knauf U, Mundegar RR, Wernig A. The ontogeny of soleus muscles in mdx and wild type mice. Neuromuscular Disorders. 2005 Jan;15(1):57\u201364. DOI: 10.1016\/j.nmd.2004.09.011","journal-title":"Neuromuscular Disorders."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/B0-12-227055-X\/00039-0","volume-title":"AMINO ACIDS | Determination. Encyclopedia Of Food Sciences And Nutrition","author":"Williams AP","year":"2003","unstructured":"Williams, A.P.. AMINO ACIDS | Determination. Encyclopedia Of Food Sciences And Nutrition, [s.l.], p.192\u2013197, 2003. Elsevier. DOI:"},{"issue":"6","key":"ref40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/jcm8060775","article-title":"Nutritional Laboratory Markers in Malnutrition","volume":"31","author":"Keller U","unstructured":"Keller U. Nutritional Laboratory Markers in Malnutrition. Journal of Clinical Medicine. 2019 May 31;8(6):775. DOI: 10.3390\/jcm8060775","journal-title":"Journal of Clinical Medicine. 2019 May"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2000.89.1.81","author":"Janssen I","year":"2000","unstructured":"Janssen I, Heymsfield SB, Wang Z, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18\u201388 year. Journal of Applied Physiology. 2000 Jul 1;89(1):81\u20138. DOI: 10.1152\/jappl.2000.89.1.81"},{"issue":"5","key":"ref42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.exger.2013.02.012","article-title":"The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size","volume":"48","author":"Nilwik R","year":"2013","unstructured":"Nilwik R, Snijders T, Leenders M, Groen BBL, van Kranenburg J, Verdijk LB, et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Experimental Gerontology. 2013 May;48(5):492\u20138. DOI: 10.1016\/j.exger.2013.02.012","journal-title":"Experimental Gerontology"},{"key":"ref43","doi-asserted-by":"publisher","author":"Bernasconi P","unstructured":"Bernasconi P, Torchiana E, Confalonieri P, Brugnoni R, Barresi R, Mora M, et al. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. Journal of Clinical Investigation. 1995 Aug 1;96(2):1137\u201344. DOI: 10.1172\/JCI118101","DOI":"10.1172\/JCI118101"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cyto.2017.12.006","article-title":"Identification of plasma interleukins as biomarkers for deflazacort and omega-3 based Duchenne muscular dystrophy therapy","volume":"102","author":"Carvalho SC","unstructured":"Carvalho SC, Matsumura CY, Santo Neto H, Marques MJ. Identification of plasma interleukins as biomarkers for deflazacort and omega-3 based Duchenne muscular dystrophy therapy. Cytokine. 2018 Feb;102:55\u201361. DOI: 10.1016\/j.cyto.2017.12.006","journal-title":"Cytokine. 2018 Feb"},{"key":"ref45","doi-asserted-by":"publisher","author":"Ham DJ","unstructured":"Ham DJ, Gardner A, Kennedy TL, Trieu J, Naim T, Chee A, et al. Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin\/utrophin null mice. Scientific Reports [Internet]. 2019 Sep 10;9(1). DOI: 10.1038\/s41598-019-49140-x","DOI":"10.1038\/s41598-019-49140-x"},{"issue":"2","key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4598(200102)24:2<192::aid-mus40>3.0.co;2-s","article-title":"Metabolic shifts and myocyte hypertrophy in deflazacort treatment of mdx mouse cardiomyopathy","volume":"24","author":"Skrabek RQ","year":"2016","unstructured":"Skrabek RQ; Anderson JE. Metabolic shifts and myocyte hypertrophy in deflazacort treatment of mdx mouse cardiomyopathy. Muscle & Nerve. 2016;24(2). DOI: 10.1002\/1097-4598(200102)24:2<192::aid-mus40>3.0.co;2-s","journal-title":"Muscle & Nerve"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2019.00172","article-title":"Glycine Protects Muscle Cells From Wasting in vitro via mTORC1 Signaling","volume":"13","author":"Caldow MK","year":"2019","unstructured":"Caldow MK, Ham DJ, Trieu J, Chung JD, Lynch GS, Koopman R. Glycine Protects Muscle Cells From Wasting in vitro via mTORC1 Signaling. Frontiers in Nutrition. 2019 Nov 13. DOI: 10.3389\/fnut.2019.00172","journal-title":"Frontiers in Nutrition"},{"key":"ref48","author":"Lin C","year":"2020","unstructured":"Lin C, Han G, Ning H, Song J, Ran N, Yi X, et al. Glycine Enhances Satellite Cell Proliferation, Cell Transplantation, and Oligonucleotide Efficacy in Dystrophic Muscle. Molecular Therapy. 2020 May;28(5):1339\u201358. DOI:"},{"issue":"3","key":"ref49","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/jn\/134.3.489","article-title":"Glutathione Metabolism and Its Implications for Health","volume":"1","author":"Wu G","unstructured":"Wu G, Fang Y.Z, Yang S, Lupton JR, Turner ND. Glutathione Metabolism and Its Implications for Health. The Journal of Nutrition. 2004 Mar 1.;134(3):489\u201392. DOI: 10.1093\/jn\/134.3.489","journal-title":"The Journal of Nutrition. 2004 Mar"},{"issue":"1","key":"ref50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00075197-200501000-00007","article-title":"Skeletal muscle glutamate metabolism in health and disease: state of the art. Current Opinion in Clinical Nutrition and Metabolic Care","volume":"8","author":"Rutten EP","year":"2005","unstructured":"Rutten EP, Engelen MP, Schols AM, Deutz NE. Skeletal muscle glutamate metabolism in health and disease: state of the art. Current Opinion in Clinical Nutrition and Metabolic Care. 2005 Jan;8(1):41\u201351. DOI: 10.1097\/00075197-200501000-00007"},{"key":"ref51","doi-asserted-by":"publisher","author":"Petrillo S","unstructured":"Petrillo S, Pelosi L, Piemonte F, Travaglini L, Forcina L, Catteruccia M, et al. Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway. Human Molecular Genetics. 2017 May 3;26(14):2781\u201390. DOI:10.1093\/hmg\/ddx173","DOI":"10.1093\/hmg\/ddx173"},{"issue":"3","key":"ref52","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.3390\/metabo7030038","article-title":"Non-Targeted Metabolomics Analysis of Golden Retriever Muscular Dystrophy-Affected Muscles Reveals Alterations in Arginine and Proline Metabolism, and Elevations in Glutamic and Oleic Acid In Vivo","volume":"29","author":"Abdullah M","unstructured":"Abdullah M, Kornegay JN, Honcoop A, Parry TL, Balog-Alvarez CJ, O\u2019Neal SK, et al. Non-Targeted Metabolomics Analysis of Golden Retriever Muscular Dystrophy-Affected Muscles Reveals Alterations in Arginine and Proline Metabolism, and Elevations in Glutamic and Oleic Acid In Vivo. Metabolites. 2017 Jul 29;7(3):E38. DOI: 10.3390\/metabo7030038","journal-title":"Metabolites. 2017 Jul"},{"key":"ref53","doi-asserted-by":"publisher","author":"Lafert\u00e9 RO","unstructured":"Lafert\u00e9 RO, Rosenkrantz H, Berlinguet L. TRANSAMINATION IN MUSCULAR DYSTROPHY AND THE EFFECT OF EXOGENOUS GLUTAMATE: A STUDY ON VITAMIN E DEFICIENT RABBITS, AND MICE WITH HEREDITARY DYSTROPHY. Canadian Journal of Biochemistry and Physiology. 1963 Jan 1;41(1):1423\u201332. DOI: 10.1139\/y63-162","DOI":"10.1139\/y63-162"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3038923\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3038923\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T15:09:00Z","timestamp":1695049740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3038923\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":53,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3038923\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s13395-023-00325-z","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,6,13]]},"subtype":"preprint"}}